Literature DB >> 1826945

Antagonism at the glycine site on the NMDA receptor reduces spinal nociception in the rat.

A H Dickenson1, E Aydar.   

Abstract

The effects of 7-chlorokynurenate (7CK), an antagonist at the allosteric glycine site associated with the N-methyl-D-aspartate receptor, applied intrathecally, were tested on nociceptive neurones in the dorsal horn of the anaesthetized rat. 7CK reduced the frequency dependent potentiation (wind-up) of the cells to repeated C-fibre stimulation and the related post-discharges at doses which had minimal effects on the C and A-fibre inputs onto the cells although these were reduced by higher doses of the antagonist. Only the effects on post-discharges and wind-up were reversed by application of glycine. Furthermore the neuronal responses to formalin were also reduced by 7CK at doses which did not influence input. The results show that activation of the glycine site is a requirement for spinal NMDA receptor activation and further emphasize the involvement of this receptor in maintained nociceptive processes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826945     DOI: 10.1016/0304-3940(91)90700-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus.

Authors:  Xiao-lei Zhang; John A Sullivan; Joseph R Moskal; Patric K Stanton
Journal:  Neuropharmacology       Date:  2008-08-29       Impact factor: 5.250

Review 2.  Glutamate receptors and nociception: implications for the drug treatment of pain.

Authors:  M E Fundytus
Journal:  CNS Drugs       Date:  2001-01       Impact factor: 5.749

3.  Role of spinal NMDA receptors, protein kinase C and nitric oxide synthase in the hyperalgesia induced by magnesium deficiency in rats.

Authors:  S Begon; G Pickering; A Eschalier; A Mazur; Y Rayssiguier; C Dubray
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

4.  Intrathecally administered NMDA receptor antagonists reduce the MAC of isoflurane in rats.

Authors:  K Ishizaki; N Yoshida; D M Yoon; M H Yoon; M Sudoh; T Fujita
Journal:  Can J Anaesth       Date:  1996-07       Impact factor: 5.063

5.  The contribution of NMDA receptor activation to spinal c-Fos expression in a model of inflammatory pain.

Authors:  V Chapman; P Honoré; J Buritova; J M Besson
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

6.  Effects of a partial agonist and a full antagonist acting at the glycine site of the NMDA receptor on inflammation-induced mechanical hyperalgesia in rats.

Authors:  J M Laird; G S Mason; J Webb; R G Hill; R J Hargreaves
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

Review 7.  The spinal actions of nonsteroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects.

Authors:  K McCormack
Journal:  Drugs       Date:  1994       Impact factor: 9.546

8.  Kynurenine metabolites and migraine: experimental studies and therapeutic perspectives.

Authors:  Annamária Fejes; Arpád Párdutz; József Toldi; László Vécsei
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.